MapLight Therapeutics News and Activities

Acquisition, funding and merger involving MapLight Therapeutics.

• MapLight Therapeutics has just announced a $227 Million fundraising (posted on October 9 2025).
• MapLight Therapeutics has just announced a $373 Million fundraising (posted on July 30 2025).

View the org chart displaying its 37 main executives

Most searched biographies at MapLight Therapeutics

• Christopher Kroeger, Chief Executive Officer, Founder and Director
• George Pavlov, Director
• Robert Malenka, Director

Popular executive movements at MapLight Therapeutics

• Stephen Repucc has joined the company as Vice President, People and Experience  (posted on October 9 2025).

Create your alert
to follow the executive moves at MapLight Therapeutics.

MapLight Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by MapLight Therapeutics

• News | MapLight Therapeutics

Social media about MapLight Therapeutics

• MapLight Therapeutics on Wikipedia, Google News & Yahoo Finance
• MapLight Therapeutics on LinkedIn, X (Twitter) & YouTube